Advertisement
Advertisement
U.S. Markets close in 2 hrs 23 mins
Advertisement
Advertisement
Advertisement
Advertisement

IVERIC bio, Inc. (ISEE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
13.19-0.41 (-3.01%)
As of 01:37PM EDT. Market open.
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • j
    josh
    8/2/22
    UBS Initiates Coverage IVERIC bio, Inc. (ISEE) $20.00 Buy
  • T
    Thomas
    Wow 5100+ Aug 19 12.5 calls today
  • T
    Thomas
    Good volume this morning and a purchase of 1000 Aug 12.5 calls!
    Bullish
  • T
    Thomas
    Iveric Bio to Report Second Quarter 2022 Financial Results and Host Conference Call on Tuesday, July 26, 2022

    Usually companies announce 2-3 weeks in advance. Why the sudden announcement? Will there be something noteworthy happening beforehand?
  • *
    * LEGENDS ! MEGL
    $MEGL conversation
    All Legends, Lotto Play here>> MEGL << Up (+2,325.00%) At close: 04:00PM Friday, August 5, 2022.
    It's up $32 dollars Extended Hours. --- * J The Legend !

    $MEGL $AMTD $HKD $FAZE $SYM $KPLT $ISEE $DARE $ENVB $UWMC $ANY $DVAX $EXPR $KPTI $CHS $AIKI $AEI $APRN $EVGO $PHUN $HYLN $ MVIS $GOEV $MNMD $ROOT $MKD $BTBT $MMAT $NAK $AUPH $NNDM $SDC $GSAT $STEM $RDBX $IDEX $WE $DBGI $BNGO $BKKT $BB $OCGN $CLOV $ATER
    $AEX $ARKK $AAL $AMC $AMD $AAPL $AMZN $APRN $ATER
    $BBBY $BABA $BBI $BWV $BMEA $BBIG $BEAT $CCL $CEI
    $ERIC $RIDE $SPCE $SKLZ $CSCW $FSR $GRAB $WISH $CLF $DIDI $FUBO $OPEN $BRQS $CYN $CEI $YLRY $FAMI $NOK $LCID $VALE $MULN $BBIG $SNDL $RIVN $CFVI $DWAC
    $DAL $DKNG $GME $GLD $GLE $HOOD $HYMC $ITP $ING $IGEX
    $JBLU $LCID $LUV $MULN $META $MULN $NCLH $NDX $PVSP
    $QQQ $RCL $RDBX $SAVE $STRN $STEM $SPY $SAVE $SPX $SOFI $SNOA $TWTR $TKAT $TSLA $UAL $VERU $XRTX $XCUR $CENN $AEI $LYFT $JWN $DKS $WEN $INTU $NERO $WEJO $TTOO $VYNE $SIOX $ALNA $ROKU $ARKK $COMP $BHLB $ADER $OCGN $ALZN $ADTX $PLTR, $RKT $SOFI $SNDL $AGRX $DPLS $ADN $RIGL $QNRX $BOXD $EFOI $ASO, $SIGA $GFAI $REVB $FSRD $TOUR $CMRX, $CELZ, $FNHC $NBEV $COWN $RNW $OCFT $NISN $AAL $WISH $SOLO $APDN $BNGO $INO $VXRT $GCLT $CHNC $HIRU $VXIT $SSOF $GMPR $PASO $GMEV $SRMX $SANP $NNRX $FTEG $EEGI $CBDL $KYNC $WDLF $COWI $RMRK $FCGD $GWHP $GNBT $WLYYF $USEI $TGHI $NIOBF $BFCH $ZAAG $USMJ $JPEX $CZNI $MSPC $QNRX $LUNC.X $INPX $META $NVDA $MU $AMD $OXY $XOM $RIG $MRO $SWM $CVX $AMC $RBLX $DKNG $AAL $CCL $NCLH $CSX $PLTR $CLVS $MRNA$EVFM $LXRX $FCX $GOLD $KGC $HYMC $PGEN $GRAB $FFIE $DNA $NU $BLUE $UPS $KO $GM $MCD $GE $RTX $MMM $ADM $ACI $CNC $KMB $GLW $FISV $TRU $UBS $PHM $ECL $PII $ONB $CEQP $GPK $XRX $ARCC $IRDM $PCAR $MSCI $MCO $AAN $SSTK $FELE $PEBO $HUBB $WSO $AVNT $FFWM $PNR $ST $AWI $NXRT $CAC $CVLT
  • *
    * LEGENDS ! XELA
    $XELA conversation
    Hello Legends >> XELA << It's time to put the shawts on the CrAzY Train, and send them away !
    >> XELA << I'm In. --- * J The Legend !

    $AMTD $HKD $FAZE $SYM $KPLT $ISEE $DARE $ENVB $UWMC $ANY $DVAX $EXPR $KPTI $CHS $AIKI $AEI $APRN $EVGO $PHUN $HYLN $ MVIS $GOEV $MNMD $ROOT $MKD $BTBT $MMAT $NAK $AUPH $NNDM $SDC $GSAT $STEM $RDBX $IDEX $WE $DBGI $BNGO $BKKT $BB $OCGN $CLOV $ATER
    $AEX $ARKK $AAL $AMC $AMD $AAPL $AMZN $APRN $ATER
    $BBBY $BABA $BBI $BWV $BMEA $BBIG $BEAT $CCL $CEI
    $ERIC $RIDE $SPCE $SKLZ $CSCW $FSR $GRAB $WISH $CLF $DIDI $FUBO $OPEN $BRQS $CYN $CEI $YLRY $FAMI $NOK $LCID $VALE $MULN $BBIG $SNDL $RIVN $CFVI $DWAC
    $DAL $DKNG $GME $GLD $GLE $HOOD $HYMC $ITP $ING $IGEX
    $JBLU $LCID $LUV $MULN $META $MULN $NCLH $NDX $PVSP
    $QQQ $RCL $RDBX $SAVE $STRN $STEM $SPY $SAVE $SPX $SOFI $SNOA $TWTR $TKAT $TSLA $UAL $VERU $XRTX $XCUR $CENN $AEI $LYFT $JWN $DKS $WEN $INTU $NERO $WEJO $TTOO $VYNE $SIOX $ALNA $ROKU $ARKK $COMP $BHLB $ADER $OCGN $ALZN $ADTX $PLTR, $RKT $SOFI $SNDL $AGRX $DPLS $ADN $RIGL $QNRX $BOXD $EFOI $ASO, $SIGA $GFAI $REVB $FSRD $TOUR $CMRX, $CELZ, $FNHC $NBEV $COWN $RNW $OCFT $NISN $AAL $WISH $SOLO $APDN $BNGO $INO $VXRT $GCLT $CHNC $HIRU $VXIT $SSOF $GMPR $PASO $GMEV $SRMX $SANP $NNRX $FTEG $EEGI $CBDL $KYNC $WDLF $COWI $RMRK $FCGD $GWHP $GNBT $WLYYF $USEI $TGHI $NIOBF $BFCH $ZAAG $USMJ $JPEX $CZNI $MSPC $QNRX $LUNC.X $INPX $META $NVDA $MU $AMD $OXY $XOM $RIG $MRO $SWM $CVX $AMC $RBLX $DKNG $AAL $CCL $NCLH $CSX $PLTR $CLVS $MRNA$EVFM $LXRX $FCX $GOLD $KGC $HYMC $PGEN $GRAB $FFIE $DNA $NU $BLUE $UPS $KO $GM $MCD $GE $RTX $MMM $ADM $ACI $CNC $KMB $GLW $FISV $TRU $UBS $PHM $ECL $PII $ONB $CEQP $GPK $XRX $ARCC $IRDM $PCAR $MSCI $MCO $AAN $SSTK $FELE $PEBO $HUBB $WSO $AVNT $FFWM $PNR $ST $AWI $NXRT $CAC $CVLT
    Bullish
  • *
    * LEGENDS ! AMTD $1000
    $AMTD conversation
    We'll take >> AMTD << For $1000 Alfred. ----- *J The Legend !

    $AMTD $HKD $FAZE $SYM $KPLT $ISEE $DARE $ENVB $UWMC $ANY $DVAX $EXPR $KPTI $CHS $AIKI $AEI $APRN $EVGO $PHUN $HYLN $ MVIS $GOEV $MNMD $ROOT $MKD $BTBT $MMAT $NAK $AUPH $NNDM $SDC $GSAT $STEM $RDBX $IDEX $WE $DBGI $BNGO $BKKT $BB $OCGN $CLOV $ATER
    $AEX $ARKK $AAL $AMC $AMD $AAPL $AMZN $APRN $ATER
    $BBBY $BABA $BBI $BWV $BMEA $BBIG $BEAT $CCL $CEI
    $ERIC $RIDE $SPCE $SKLZ $CSCW $FSR $GRAB $WISH $CLF $DIDI $FUBO $OPEN $BRQS $CYN $CEI $YLRY $FAMI $NOK $LCID $VALE $MULN $BBIG $SNDL $RIVN $CFVI $DWAC
    $DAL $DKNG $GME $GLD $GLE $HOOD $HYMC $ITP $ING $IGEX
    $JBLU $LCID $LUV $MULN $META $MULN $NCLH $NDX $PVSP
    $QQQ $RCL $RDBX $SAVE $STRN $STEM $SPY $SAVE $SPX $SOFI $SNOA $TWTR $TKAT $TSLA $UAL $VERU $XRTX $XCUR $CENN $AEI $LYFT $JWN $DKS $WEN $INTU $NERO $WEJO $TTOO $VYNE $SIOX $ALNA $ROKU $ARKK $COMP $BHLB $ADER $OCGN $ALZN $ADTX $PLTR, $RKT $SOFI $SNDL $AGRX $DPLS $ADN $RIGL $QNRX $BOXD $EFOI $ASO, $SIGA $GFAI $REVB $FSRD $TOUR $CMRX, $CELZ, $FNHC $NBEV $COWN $RNW $OCFT $NISN $AAL $WISH $SOLO $APDN $BNGO $INO $VXRT $GCLT $CHNC $HIRU $VXIT $SSOF $GMPR $PASO $GMEV $SRMX $SANP $NNRX $FTEG $EEGI $CBDL $KYNC $WDLF $COWI $RMRK $FCGD $GWHP $GNBT $WLYYF $USEI $TGHI $NIOBF $BFCH $ZAAG $USMJ $JPEX $CZNI $MSPC $QNRX $LUNC.X $INPX $META $NVDA $MU $AMD $OXY $XOM $RIG $MRO $SWM $CVX $AMC $RBLX $DKNG $AAL $CCL $NCLH $CSX $PLTR $CLVS $MRNA$EVFM $LXRX $FCX $GOLD $KGC $HYMC $PGEN $GRAB $FFIE $DNA $NU $BLUE $UPS $KO $GM $MCD $GE $RTX $MMM $ADM $ACI $CNC $KMB $GLW $FISV $TRU $UBS $PHM $ECL $PII $ONB $CEQP $GPK $XRX $ARCC $IRDM $PCAR $MSCI $MCO $AAN $SSTK $FELE $PEBO $HUBB $WSO $AVNT $FFWM $PNR $ST $AWI $NXRT $CAC $CVLT
  • S
    SWAMI
    Above $11.30 would be nice today and above $12 next week even better. Give it that I think I can...attitude.
    Good Luck everyone.
  • S
    SWAMI
    I like this stock but until they really start making money it's tough to watch. I buy under 10 and load up until we hit a 1 year price target. Curious what people think would be that target price besides what is out there?
  • j
    josh
    IVERIC bio (ISEE) reported a Q2 net loss of $0.41 per diluted share, compared with a loss of $0.32 a year earlier.

    Analysts polled by Capital IQ expected a loss of $0.32.

    As expected, no revenue for the quarter ended June 30 was reported.

    Operating expenses were $49.8 million in Q2, compared with $30.2 million a year earlier.

    As of June 30, the company said it had $312 million in cash, cash equivalents and available-for-sale securities, compared with $381.7 million as of Dec. 31, 2021. The company said it expects to have between $260 million to $270 million by end of 2022.
  • T
    Thomas
    Analysts have price targets of 24-30. Seems like a good time to add.
  • j
    josh
    6/8/22
    Bank of America Securities Initiated IVERIC bio, Inc. (ISEE) $18.00 Buy
    Guggenheim Initiated IVERIC bio, Inc. (ISEE) $30.00 Buy
  • j
    josh
    (Nasdaq: ISEE) today announced financial and operating results for the fiscal quarter ended September 30, 2020 and provided a general business update.

    “It has been a landmark year as we have achieved several major milestones for Zimura,” stated Glenn P. Sblendorio, Chief Executive Officer and President of IVERIC bio. “Over the past year, we announced positive 12-month and 18-month results from our GATHER1 Phase 3 clinical trial of Zimura for the treatment of geographic atrophy secondary to age-related macular degeneration. We initiated patient enrollment in GATHER2, our second Phase 3 clinical trial for the treatment of GA secondary to AMD. Additionally, we strengthened our balance sheet, advanced our two lead gene therapy product candidates to be on track to enter into the clinic next year and identified a lead compound for our HtrA1 inhibitor program.”

    Pravin U. Dugel, M.D., Chief Strategy and Business Officer of IVERIC bio added, “We are excited about the momentum generated with Zimura as a potential treatment for GA and, based on scientific data, Zimura‘s potential impact in wet (neovascular) AMD and in earlier stages of dry AMD. We are also encouraged by our HtrA1 inhibitor, IC-500, which we believe could be another important target in the treatment of AMD. Looking forward, our goal is to expand our footprint in multiple stages and types of AMD, dry and wet. We intend to do this by potentially studying Zimura in additional indications and by advancing the development of IC-500. We expect to make great strides in 2021, as we continue to move our pipeline of therapeutics and gene therapy product candidates forward.”
  • j
    josh
    Wedbush Initiates Coverage IVERIC bio, Inc. (ISEE) Outperform $13.00
    Wedbush’s David Nierengarten initiated coverage of Iveric Bio with an Outperform rating and a price target of $13.

    The Thesis

    Geographic atrophy is estimated to represent a market opportunity of over $1 billion, with the current patient population at more than 1 million, Nierengarten said in the note.

    In October, Iveric Bio had announced Zimura showed positive results in slowing the growth of lesions in its Phase 2 study. The company’s lead asset is also being investigated in Stargardt disease and data from this study could come as early as in the back half of 2002, the analyst noted.

    Nierengarten expects more details of the trial design for Zimura’s pivotal study to be disclosed at Iveric Bio’s R&D investor symposium on Jan. 14.

    He further wrote, “The company is also building a portfolio of gene therapy candidates, with the first program in autosomal dominant retinitis pigmentosa (adRP) likely to enter the clinic late this year.”
  • j
    josh
    IVERIC bio Announces Positive Zimura 18 Month Data Supporting the 12 Month Efficacy Findings: Continuous Positive Treatment Effect with Favorable Safety Profile in Geographic Atrophy Secondary to Age-Related Macular Degeneration in a Phase 3 Trial
  • D
    Diane
    Re-Dime a dozen. You do know that this stock changed its name from Ophthotech Corp to dissociate it from two phase 3 trials failures that caused the stock to plummet 84%. Reminds me of the Baker's holding of AQST that fell 50% and now is NLTX after one of their top CEO's left SGEN to merge AQST with NLTX so Baker's could recoup their losses. I was on it from the get go and profited right along side of them. It's all legal. Wall Street is a total rigged game so never buy at a 52 week high. Check out insider selling (form 4) in Jan. Some sold at $8.00.
  • T
    Tyzoid8
    Now we will see what occurs when everyone who already sold at a huge profit are out
    and the only ones left are the ones that bought those shares from the profit takers.
    Where do you think the price will go now?
  • S
    Sir John T
    Looking at the technicals…..we have clear skies to $20++.

    With a strong market this coming week for small caps and biotechs, we could do very well…….but what do I know?

    😉
Advertisement
Advertisement